Physician

Endocrinology

Dr. Samuel L. Abbate, MD

Samuel Abbate practices Endocrinology. He attended University of Illinois College of Medicine. He received awards:"Diabetes Recognition Program" and "Meaningful Use Stage 1 Certification". Dr. Samuel L. Abbate is also published. He has 1 publication published. The lastest publication: "Hyperglycemia predicts mortality after CABG: postoperative hyperglycemia predicts dramatic increases in mortality after coronary artery bypass graft surgery.' Samuel L. Abbate, MD accepts all Medicare patients.

Publications

Hyperglycemia predicts mortality after CABG: postoperative hyperglycemia predicts dramatic increases in mortality after coronary artery bypass graft surgery.

Schools

University of Illinois At Chicago College of Medicine

Conditions Treated

Abnormal Thyroid
Adrenal Insufficiency
Calcium Metabolism Disorders
Cushing's Syndrome
View All

Doctors Specialties

Endocrinology

Accepted Insurances

Choice Plus POS II
Assurant Health
Blue Card PPO
Cigna
Commercial Insurance Company
First Choice Health
GEHA
HealthSmart
Humana
Mail Handlers Benefit Plan (MHBP)
Medicaid
Medicare MCR
Heritage Signature
Principal Life
United Healthcare
Wells Fargo Insurance

Awards

Diabetes Recognition Program
Meaningful Use Stage 1 Certification

Education

University of Washington
Cleveland Clinic Foundation
McGaw Medical Center of Northwestern University
University of Illinois College of Medicine

Drug Facts

NPI NUMBER		1316953409
NPPES Provider LastName		ABBATE
NPPES Provider FirstName		SAMUEL
NPPES Provider ZIPCode		996547299
NPPES Provider State		AK
Specialty Description		Endocrinology
Total Claim Count		4637.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1316953409
Last Name Of The Provider	ABBATE
First Name Of The Provider	SAMUEL
View All